NasdaqGM - Nasdaq Real Time Price USD

MediWound Ltd. (MDWD)

17.52
+0.07
+(0.37%)
At close: May 9 at 4:00:00 PM EDT
17.52
0.00
(0.00%)
After hours: May 9 at 4:02:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
20,222
20,222
18,686
26,496
23,763
Cost of Revenue
17,588
17,588
15,108
13,331
14,992
Gross Profit
2,634
2,634
3,578
13,165
8,771
Operating Expense
22,016
22,016
19,079
20,826
19,992
Operating Income
-19,382
-19,382
-15,501
-7,661
-11,221
Net Non Operating Interest Income Expense
-35
-35
1,103
-2,258
-1,792
Other Income Expense
-10,746
-10,746
7,867
-9,602
-511
Pretax Income
-30,163
-30,163
-6,531
-19,521
-13,524
Tax Provision
61
61
185
78
27
Net Income Common Stockholders
-30,224
-30,224
-6,716
-19,599
-13,551
Diluted NI Available to Com Stockholders
-30,224
-30,224
-6,716
-19,599
-13,551
Basic EPS
-2.91
-3.03
-0.75
-3.93
-3.50
Diluted EPS
-2.91
-3.03
-0.75
-3.93
-3.50
Basic Average Shares
9,565.44
9,959.72
9,013.14
4,987
3,892
Diluted Average Shares
9,565.44
9,959.72
9,013.14
4,987
3,892
Total Operating Income as Reported
-19,400
-19,400
-15,290
-8,345
-11,221
Total Expenses
39,604
39,604
34,187
34,157
34,984
Net Income from Continuing & Discontinued Operation
-30,224
-30,224
-6,716
-19,599
-13,551
Normalized Income
-21,748.88
-21,748.88
-12,930.93
-12,553.78
-13,177.97
Interest Income
2,048
2,048
2,341
270
11
Interest Expense
752
752
427
0
903
Net Interest Income
-35
-35
1,103
-2,258
-1,792
EBIT
-29,411
-29,411
-6,104
-19,521
-12,621
EBITDA
-27,928
-27,928
-4,801
-18,249
-11,383
Reconciled Cost of Revenue
16,333
16,333
14,040
12,333
14,037
Reconciled Depreciation
1,483
1,483
1,303
1,272
1,238
Net Income from Continuing Operation Net Minority Interest
-30,224
-30,224
-6,716
-19,599
-13,551
Total Unusual Items Excluding Goodwill
-10,728
-10,728
7,867
-8,918
-511
Total Unusual Items
-10,728
-10,728
7,867
-8,918
-511
Normalized EBITDA
-17,200
-17,200
-12,668
-9,331
-10,872
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,252.88
-2,252.88
1,652.07
-1,872.78
-137.97
12/31/2021 - 3/20/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CLGN CollPlant Biotechnologies Ltd.
1.8200
-0.55%
 
URGN UroGen Pharma Ltd.
10.38
-2.72%
 
SCPH scPharmaceuticals Inc.
2.4400
-2.79%
 
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
 
CMPX Compass Therapeutics, Inc.
1.8200
+2.25%
 
VCEL Vericel Corporation
41.73
-0.33%
 
BRTX BioRestorative Therapies, Inc.
1.8000
-0.55%
 
INAB IN8bio, Inc.
0.1574
-6.25%
 
CGEN Compugen Ltd.
1.2600
-2.33%
 
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%